-
公开(公告)号:US20190144555A1
公开(公告)日:2019-05-16
申请号:US16091456
申请日:2017-04-04
Applicant: UNIVERSITÄT STUTTGART , BALIOPHARM AG
Inventor: Roland KONTERMANN , Klaus PFIZENMAIER , Fabian RICHTER , Kirstin ZETTLITZ , Peter SCHEURICH , Andreas HERRMANN
CPC classification number: C07K16/2878 , A61P37/06 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/622 , C07K2317/76 , C07K2317/92 , C07K2317/94
Abstract: The invention provides for an inhibitor of the huTNFRI receptor which is a human or humanized antibody construct that monovalently recognizes huTNFRI through an antigen-binding moiety, which is characterized by specific CDR sequences, a pharmaceutical preparation thereof, method of producing the inhibitor and the medical use of the inhibitor.
-
公开(公告)号:US20210002376A1
公开(公告)日:2021-01-07
申请号:US16982714
申请日:2018-03-22
Applicant: UNIVERSITÄT STUTTGART
Inventor: Oliver SEIFERT , Roland KONTERMANN , Fabian RICHTER
Abstract: The present invention relates to a modular multivalent antigen-binding protein complex, use of the antigen-binding protein complex in medicine and use of the antigen-binding protein complex in the prophylaxis, treatment or diagnosis of a disorder or disease.
-
公开(公告)号:US20240059779A1
公开(公告)日:2024-02-22
申请号:US18452699
申请日:2023-08-21
Applicant: UNIVERSITÄT STUTTGART
Inventor: Oliver SEIFERT , Roland KONTERMANN , Fabian RICHTER
IPC: C07K16/28 , A61P35/00 , C07K16/32 , A61K39/395
CPC classification number: C07K16/2863 , A61P35/00 , C07K16/2878 , C07K16/32 , A61K39/39533 , A61K38/00
Abstract: The present invention relates to a modular multivalent antigen-binding protein complex, use of the antigen-binding protein complex in medicine and use of the antigen-binding protein complex in the prophylaxis, treatment or diagnosis of a disorder or disease.
-
公开(公告)号:US20200172619A1
公开(公告)日:2020-06-04
申请号:US16615536
申请日:2018-06-01
Applicant: UNIVERSITÄT STUTTGART
Inventor: Fabian RICHTER , Oliver SEIFERT , Roland KONTERMANN
Abstract: The present invention provides a protein complex comprising heterodimerizing regions HRI and HRII, each comprised of antiparallel β-strands and intervening regions wherein HRI and HRII are each interspersed fusion proteins of two human constant regions of an immunoglobulin or immunoglobulin-like proteins. The present invention also provides nucleic acid molecules comprising a sequence encoding said protein complexes and vectors comprising the nucleic acid. The present invention also provides the protein complex, the nucleic acid and the vector for use as a medicament. The present invention further provides a method of determining the amino acid sequence of HRI and/or of the amino acid sequence of HRII. The present invention also provides a method of producing amino acid chains of HRI and/or amino acid chains of HRII. The present invention further provides the protein complex for use in the N prophylaxis, treatment or diagnosis of a disorder or a disease.
-
-
-